Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

CHINA MEDICAL UNIVERSITY HOSPITAL

🇹🇼Taiwan

Country: 🇹🇼Taiwan

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.cmuh.cmu.edu.tw

Clinical Trials

Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia

Phase 1

Conditions: Bronchopulmonary Dysplasia
Extremely Premature Infants
Severe BPD That Conventional Therapies Has Failed
No Severe Congenital Anomalies
no Severe IVH Neither Cystic PVL

Interventions: Biological: ucMSCs
Other: Normal saline

First Posted Date: 2010-09-23

Last Posted Date: 2010-09-23

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 10

Registration Number: NCT01207869

Locations: 🇨🇳
China Medical University Hospital, Taichung,, Taiwan

The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)

Phase 4

Completed

Conditions: Ischemic Stroke

Interventions: Other: placebo
Drug: Cilostazol

First Posted Date: 2010-08-26

Last Posted Date: 2013-10-07

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 801

Registration Number: NCT01188824

Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants

Phase 1

Conditions: Extremely Premature Infants
PDA
Oral Ibuprofen
IV Ibuprofen

Interventions: Drug: iv ibuprofen
Drug: oral ibuprofen

First Posted Date: 2010-06-23

Last Posted Date: 2010-06-23

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 70

Registration Number: NCT01149564

Locations: 🇨🇳
China Medical University Hospital, Taichung, Taiwan

The Effect of a Diet- and Exercise- Related Weight Control Intervention Program on Obesity in Adult Aged 40 and Over

Not Applicable

Completed

Conditions: Metabolic Syndrome
Obesity

Interventions: Behavioral: Individualized education
Behavioral: Grouped education

First Posted Date: 2009-12-29

Last Posted Date: 2009-12-29

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 240

Registration Number: NCT01040546

Locations: 🇨🇳
Department of Famility Medicine,China Medical University Hospital, Taichung, Taiwan

N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)

Phase 2

Completed

Conditions: Obsessive Compulsive Disorder

First Posted Date: 2009-12-15

Last Posted Date: 2009-12-29

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 30

Registration Number: NCT01031927

Locations: 🇨🇳
China Medical University Hospital, Taichung, Taiwan

N-methylglycine (Sarcosine) Treatment for Depression

Phase 2

Completed

Conditions: Major Depressive Disorder
Depression
Major Depression

Interventions: Drug: sarcosine
Drug: citalopram

First Posted Date: 2009-09-15

Last Posted Date: 2011-07-12

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 40

Registration Number: NCT00977353

Locations: 🇨🇳
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan

D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia

Phase 2

Completed

Conditions: Schizophrenias
Psychoses
Psychotic Disorders
Schizophrenic Disorders

Interventions: Drug: D-amino acid oxidase inhibition (DAAOI-1)
Drug: placebo

First Posted Date: 2009-08-17

Last Posted Date: 2011-07-11

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 52

Registration Number: NCT00960219

Locations: 🇨🇳
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan

Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

Phase 2

Completed

Conditions: Stroke
Middle Cerebral Artery Infarction

Interventions: Procedure: Intercerebral implantation of Autulogous Stem Cells
Drug: convention therapy

First Posted Date: 2009-07-31

Last Posted Date: 2011-04-21

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 30

Registration Number: NCT00950521

Locations: 🇨🇳
China Medical University Hospital, Taichung, Taiwan

Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

Phase 1

Conditions: Infant, Premature
Leukomalacia, Periventricular
Intraventricular Hemorrhage
Retinopathy of Prematurity

Interventions: Drug: recombinant human erythropoietin (rhEpo)
Drug: Normal saline

First Posted Date: 2009-05-29

Last Posted Date: 2009-05-29

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 100

Registration Number: NCT00910234

Locations: 🇨🇳
China Medical University Hospital, Taichung, Taiwan

Efficacy and Safety Study of Titrated Oral Misoprostol Solution for Labor Augmentation

Phase 4

Conditions: Labor

Interventions: Drug: Misoprostol
Drug: Oxytocin

First Posted Date: 2008-06-11

Last Posted Date: 2008-07-10

Lead Sponsor: China Medical University Hospital

Target Recruit Count: 143

Registration Number: NCT00695331

Locations: 🇨🇳
Labor Unit, Department of Obstetric and Gynecology, China Medical Univertiy Hospital, Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy